Romosozumab, Denosumab, Eldecalcitol

2 trials

Sponsors

Asai Shuji, ASAI SHUJI

Conditions

Primary osteoporosis osteoporosisRheumatic disease, Glucocoluticoid-induced osteoporosis Rheumatic disease, Glucocoluticoid-induced osteoporosis

Unknown Phase

Total REview of Anti-Sclerostin antibody Use Related to Elderly people (TREASURE) study

Active, not recruitingJPRN-jRCT1041190081

Asai ShujiPrimary osteoporosis osteoporosis

Start: 2020-01-24Target: 120Updated: 2026-06-29

Romosozumab Against GLucocorticoid-induced Osteoporosis in Rheumatic disease despite bisphosphonate over a Year

Active, not recruitingJPRN-jRCT1041190127

ASAI SHUJIRheumatic disease, Glucocoluticoid-induced osteoporosis Rheumatic disease, Glucocoluticoid-induced osteoporosis

Start: 2021-02-03Target: 100Updated: 2026-06-29